Patent ID: 11918629
Assignee: OMRIX BIOPHARMACEUTICALS LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A

Claim 0:
1. A kit comprising:
(i) a first container comprising a solution of plasma cryoprecipitate-containing component comprising fibrinogen at a concentration range of about 10 mg/ml to about 25 mg/ml and having a total protein concentration range of about 15 mg/ml to about 40 mg/ml, wherein the fibrinogen is in a range of about 50% to less than 80% of total protein by weight, wherein the cryoprecipitate is depleted from plasmin and/or plasminogen, does not comprise tranexamic acid or aprotinin, and comprises factor XIII, fibronectin and optionally one or more members selected from factor VIII, von Willebrand factor (vWF), and vitronectin; and
(ii) a second container comprising a solution of thrombin-containing component;
wherein: the cryoprecipitate-containing component comprises albumin at a concentration ranging from 1.2 mg/ml up to about 3 mg/ml; and wherein the cryoprecipitate-containing component and/or the thrombin-containing component comprise free calcium ions.